The latest teaser pitch from Jeff Brown has gotten a lot of attention from Gumshoe readers… so let’s dig in and get some answers (and yes, some readers already posted their findings in our discussions area… so we’ll see if they got the right answer). The ad is all about a microcap biotech stock that […]
Articles
Newsletter promoters LOVE dates — using a specific day in the calendar, preferably a day within the next month or two, gives a sense of urgency to an ad and makes you feel like you have to sign up RIGHT NOW to avoid missing out on the profits that can be made. And Agora is […]
I love Thanksgiving. I love that we all try to remember to slow down our lives a little bit, spend time with family and friends, and give thanks for the incredible blessings most of us enjoy and take for granted. But I also love naming our annual “Turkey” teaser stock. What is this? Well, if […]
Ernie Tremblay’s teaser pitches about imminent FDA decisions or other biotech catalysts always get a lot of attention — not necessarily because he’s always right (ARLZ did get approval for their drug, but the stock is actually down… EARS did not “double by August 31” because the trial he was teasing failed on efficacy), but […]
Antibiotic resistance is a big deal, as you undoubtedly already know — and resistant strains of various cooties are becoming more and more of a problem, particularly in hospital settings where they seem to spread like wildfire among the sick, infirm and open-wounded, but elsewhere as well. And the new wave of antibiotics is certainly […]
“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.” — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]
Antibiotics Don’t Get No Respect, But You Can Still Profit From Them[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
The Oxford Club, who gave us CEMP, which turned into Melinta, and then went bankrupt. And MUX at over $4 per share whic...
I really am a compassionate person, but sympathy and empathy have i NONE for all the pouters and whiners on Twitter toda...
$CEMP, $AKAO In a squeaker, FDA AdComm votes for an OK of Cempra’s antibiotic Cempra $CEMP just barely squeaked th...
A morning missive about Cempra ($CEMP). This is mainly for new Gummie Phil Kobi, and I am quite thrilled he joined us he...
Kenny, I think you were asking last night about Cempra $CEMP and posted a blurb from someone backing it. Obviously there...
A new recommendation today from Technology Profits Confidential for $CEMP. I would be interested to hear Dr. KSS latest...
Dr KSS, Re #233 above. You mention TTPH and Cempra (CEMP) as "starry players" in the same category as Durata, AKAO an...
Dr. KSS any thoughts on Cempra (CEMP)?...